Financials
- Market Capitalization 2.09 B
- Employee 749
- Founded 1987
- CEO John C. Jacobs
- Website www.novavax.com
- Headquarter Delaware, United States
- FIGI BBG000NVSBL7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
2.6
売上高対価格比率
1.04
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1899 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 4.01 USD | -8.03% | -16.46% | +25.31% | -24.48% | 2.15 B USD | ||
| 1905 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.36 USD | -2.22% | +2.58% | +2.33% | +27.05% | 2.14 B USD | ||
| 1922 | VCEL Vericel Corporation - Common Stock | 40.62 USD | +1.30% | -2.00% | +5.29% | +11.75% | 2.08 B USD | ||
| 1923 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.30 USD | -1.93% | -4.34% | -14.76% | -18.49% | 2.07 B USD |